Miller M R, Okubo K, Roseberry M J, Webb D J, Megson I L
Centre for Cardiovascular Science, Hugh Robson Building, University of Edinburgh, Edinburgh, Scotland, UK.
J Cardiovasc Pharmacol. 2004 Mar;43(3):440-51. doi: 10.1097/00005344-200403000-00016.
Nitric oxide (NO) and NO donors exhibit actions that are not entirely mediated by soluble guanylate cyclase (sGC). The site of NO release may influence the involvement of sGC-independent effects. Here we use spermine NONOate (SPER/NO) to release NO extracellularly, compared with other NO donors. Isolated rat femoral arteries were perfused luminally and perfusion pressure monitored. Vessels were contracted with phenylephrine (2-14 microM) in the presence of an NO synthase inhibitor (N(omega)-nitro-L-arginine methyl ester; 20 microM). Vasodilator responses to NO donors were assessed before and after perfusion of an sGC inhibitor (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one; ODQ; 20 microM), NO scavengers (hemoglobin; Hb & hydroquinone; HQ), and a superoxide generator (duroquinone; DQ). ODQ (20 microM) abolished the vasodilator responses to glyceryl trinitrate (10(-8) - 10(-3) M), and sodium nitroprusside (10(-8) - 10(-4) M), which release NO intracellularly. ODQ (20 microM) attenuated, but failed to abolish, the vasodilator responses to SPER/NO (10(-6) - 10(-3) M). ODQ abolished responses to S-nitrosoglutathione and S-nitroso-N-valeryl-D-penicillamine (10(-8) - 10(-4) M), but a small residual vasodilatation remained in response to 10(-3) M. In the presence of ODQ, the remaining vasodilatation to SPER/NO was all but abolished by scavengers of extracellular NO (Hb; 10 microM, HQ; 100 microM). Superoxide generation (DQ; 100 microM) also attenuated ODQ-resistant vasodilatation. The data suggest that, in rat femoral arteries, NO donors that are capable of releasing extracellular NO cause vasodilatation that is only partially mediated by sGC. Lack of augmentation of sGC-independent effects by superoxide suggests that they are not mediated by peroxynitrite.
一氧化氮(NO)及NO供体所表现出的作用并非完全由可溶性鸟苷酸环化酶(sGC)介导。NO的释放位点可能会影响sGC非依赖性效应的参与情况。在此,我们使用精胺亚硝基铁氰化钠(SPER/NO)与其他NO供体相比,在细胞外释放NO。对分离的大鼠股动脉进行腔内灌注,并监测灌注压力。在存在NO合酶抑制剂(N(ω)-硝基-L-精氨酸甲酯;20 μM)的情况下,用去氧肾上腺素(2 - 14 μM)使血管收缩。在灌注sGC抑制剂(1H-[1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮;ODQ;20 μM)、NO清除剂(血红蛋白;Hb和对苯二酚;HQ)以及超氧化物生成剂(杜醌;DQ)之前和之后,评估血管对NO供体扩张血管的反应。ODQ(20 μM)消除了血管对甘油三硝酸酯(10⁻⁸ - 10⁻³ M)和硝普钠(10⁻⁸ - 10⁻⁴ M)的扩张血管反应,这两种物质在细胞内释放NO。ODQ(20 μM)减弱但未能消除血管对SPER/NO(10⁻⁶ - 10⁻³ M)的扩张血管反应。ODQ消除了血管对S-亚硝基谷胱甘肽和S-亚硝基-N-戊酰-D-青霉胺(10⁻⁸ - 10⁻⁴ M)的反应,但对10⁻³ M仍有少量残余血管舒张反应。在存在ODQ的情况下,细胞外NO清除剂(Hb;10 μM,HQ;100 μM)几乎完全消除了对SPER/NO剩余的血管舒张反应。超氧化物生成(DQ;100 μM)也减弱了对ODQ耐药的血管舒张反应。数据表明,在大鼠股动脉中,能够在细胞外释放NO的NO供体引起的血管舒张仅部分由sGC介导。超氧化物未增强sGC非依赖性效应表明它们不是由过氧亚硝酸盐介导的。